EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke

Naruchorn Kijpaisalratana, Zsuzsanna Ament, Matthew B Bevers, Varun M Bhave, Ana-Lucia Garcia Guarniz, Catharine A Couch, M Ryan Irvin, W Taylor Kimberly

JAMA Network Open · 23.08.2023 · 6 (8) · e2330446

DOI: 10.1001/jamanetworkopen.2023.30446 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 23.08.2023. Verfasst von Naruchorn Kijpaisalratana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston. Hauptthemen laut MEDLINE: Ischemic Stroke, Stroke, Lacunar, White Matter, Stroke. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Although increasing evidence suggests that trimethylamine N-oxide (TMAO) is associated with atherosclerosis, little is known about whether TMAO and its related metabolites (ie, choline, betaine, and carnitine) are associated with small vessel disease.

Objective

To evaluate the association between TMAO and its related metabolites with features of cerebral small vessel disease, including white matter hyperintensity volume (WMHV) and acute lacunar infarction. Design, Setting, and Participants This cross-sectional study included patients enrolled in the Specialized Programs of Translational Research in Acute Stroke biorepository. The registry included 522 patients with acute ischemic stroke who were 18 years or older who presented at the Massachusetts General Hospital or Brigham and Women’s Hospital within 9 hours after onset between January 2007 and April 2010. The analyses in this study were conducted between November 2022 and April 2023. Exposures Plasma TMAO, choline, betaine, and carnitine were measured by liquid chromatography–tandem mass spectrometry. Main Outcomes and Measures WMHV was quantified by a semiautomated approach using signal intensity threshold with subsequent manual editing. Ischemic stroke subtype was classified using the Causative Classification System.

Results

Among 351 patients included in this study, the mean (SD) age was 69 (15) years; 209 patients (59.5%) were male and had a median (IQR) admission National Institute of Health Stroke Scale of 6 (3-13). The magnetic resonance imaging subgroup consisted of 291 patients with a mean (SD) age of 67 (15) years. Among these, the median (IQR) WMHV was 3.2 (1.31-8.4) cm 3 . TMAO was associated with WMHV after adjustment for age and sex (β, 0.15; 95% CI, 0.01-0.29; P < .001). TMAO remained significant in a multivariate analysis adjusted for age, sex, hypertension, diabetes, and smoking (β, 0.14; 95% CI, 0-0.29; P = .05). TMAO was associated with lacunar stroke but not other ischemic stroke subtypes in a model adjusted for age, sex, hypertension, diabetes, and smoking (OR, 1.67; 95% CI, 1.05-2.66; P = .03). Conclusions and Relevance In this observational study, TMAO was associated with cerebral small vessel disease determined by WMHV and acute lacunar infarction. The association was independent of traditional vascular risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeStroke, LacunarWhite MatterStrokeCerebral Small Vessel DiseasesHumansFemaleMaleAgedBetaineCross-Sectional StudiesCarnitineCholineMethylamines

Substanzen

BetaineCarnitineCholinetrimethyloxamineMethylamines

Autor:innen und Institutionen

  • Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.
  • Department of Neurology, Massachusetts General Hospital, Boston.
  • Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Division of Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Divisions of Stroke, Cerebrovascular and Critical Care Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts.

Förderung

  • NINDS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Kijpaisalratana, N., Ament, Z., Bevers, M. B., Bhave, V. M., Garcia Guarniz, A. L., Couch, C. A., Irvin, M. R., & Kimberly, W. T. (2023). Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke. JAMA Network Open, 6(8), e2330446. https://doi.org/10.1001/jamanetworkopen.2023.30446

Vancouver

Kijpaisalratana N, Ament Z, Bevers MB, Bhave VM, Garcia Guarniz AL, Couch CA, et al. Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke. JAMA Network Open. 2023;6(8):e2330446. doi:10.1001/jamanetworkopen.2023.30446

BibTeX
@article{Kijpaisalratana2023,
  author = {Kijpaisalratana, Naruchorn and Ament, Zsuzsanna and Bevers, Matthew B and Bhave, Varun M and Garcia Guarniz, Ana-Lucia and Couch, Catharine A and Irvin, M Ryan and Kimberly, W Taylor},
  title = {Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {8},
  pages = {e2330446},
  doi = {10.1001/jamanetworkopen.2023.30446}
}
Kostenlos starten →